VIKING THERAPEUTICS INC (VKTX) Stock Cash Flow
NASDAQ:VKTX - Nasdaq - US92686J1060 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -171.55M | -109.96M | -85.89M | -68.87M | -54.99M | |||
| Depreciation Amortization | 420.00K | 346.00K | 292.00K | N/A | N/A | |||
| Change In Working Capital | -6.43M | 9.36M | 3.55M | 10.19M | -2.93M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 25.03M | 12.46M | 8.68M | 10.28M | 10.33M | |||
| OPERATING CASH FLOW | -152.53M | -87.79M | -73.38M | -48.40M | -47.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | 138.24M | -553.37M | -179.09M | 54.75M | 37.96M | |||
| INVESTING CASH FLOW | 138.24M | -553.37M | -179.09M | 54.75M | 37.96M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 4.38M | 10.81M | 6.77M | -5.95M | 7.63M | |||
| Other Financing Activity | N/A | 601.65M | 264.61M | 10.11M | -750.00K | |||
| FINANCING CASH FLOW | 4.38M | 612.46M | 271.38M | 4.16M | 6.88M | |||
| Exchange Rate Effect | -114.00K | -148.00K | -30.00K | -260.00K | N/A | |||
| CHANGE IN CASH | -10.04M | -28.84M | 18.88M | 10.25M | -2.75M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -152.53M | -87.79M | -73.38M | -48.40M | -47.59M | |||
| FREE CASH FLOW | -152.53M | -87.79M | -73.38M | -48.40M | -47.59M | |||
All data in USD